日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Association Between SARS-CoV-2 Exposure, COVID-19 Vaccination and Psoriatic Arthritis-A Nested Case-Control Study

SARS-CoV-2暴露、COVID-19疫苗接种与银屑病关节炎之间的关联——一项嵌套病例对照研究

Haddad, Amir; Zabari Parnis, Ella; Stein, Nili; Gazitt, Tal; Saliba, Walid; Zisman, Devy

Prevalence of medial tibial stress syndrome in the British Armed Forces: a population-based study

英国武装部队中胫骨内侧应力综合征的患病率:一项基于人群的研究

Farquharson, Emma; Roberts, A J; Warland, A I; Parnis, N; O'Connell, N E

Physician associate (PA) students' perceptions of team-based learning (TBL) for teaching in Geriatric medicine

医师助理(PA)学生对老年医学教学中团队式学习(TBL)的看法

Aweid, Basaam; Parnis, Natalie; Harrison, David

Evaluating physician associate students' perceptions of an online team-based learning session on stroke medicine

评估医师助理学生对在线团队式卒中医学学习课程的看法

Aweid, Basaam; Wiseman, Allison; Russell, Anna; Mirchandani, Anjaly; Parnis, Natalie; Rajalingam, Preman

Epacadostat plus pembrolizumab versus placebo plus pembrolizumab for advanced urothelial carcinoma: results from the randomized phase III ECHO-303/KEYNOTE-698 study

Epacadostat联合帕博利珠单抗对比安慰剂联合帕博利珠单抗治疗晚期尿路上皮癌:来自随机III期ECHO-303/KEYNOTE-698研究的结果

Cicin, Irfan; Plimack, Elizabeth R; Gurney, Howard; Leibowitz, Raya; Alekseev, Boris Y; Parnis, Francis X; Peer, Avivit; Necchi, Andrea; Bellmunt, Joaquim; Nishiyama, Hiroyuki; Clark, Jason; Munteanu, Mihaela; Kataria, Ritesh; Jia, Calvin; Powles, Thomas; Sternberg, Cora N

Pembrolizumab plus either epacadostat or placebo for cisplatin-ineligible urothelial carcinoma: results from the ECHO-307/KEYNOTE-672 study

帕博利珠单抗联合依帕卡司他或安慰剂治疗不适合顺铂治疗的尿路上皮癌:ECHO-307/KEYNOTE-672 研究结果

Necchi, Andrea; Van der Heijden, Michiel S; Trukhin, Dmytro; Peer, Avivit; Gurney, Howard; Alekseev, Boris Y; Parnis, Francis X; Leibowitz, Raya; De Santis, Maria; Grivas, Petros; Clark, Jason; Munteanu, Mihaela; Kataria, Ritesh; Jia, Calvin; Balar, Arjun V; de Wit, Ronald

Health-Related Quality of Life Outcomes With Two Different Starting Doses of Lenvatinib in Combination With Everolimus for Previously Treated Renal Cell Carcinoma

两种不同起始剂量乐伐替尼联合依维莫司治疗既往接受过治疗的肾细胞癌患者的健康相关生活质量结局

Bergerot, Cristiane; Young Rha, Sun; Pal, Sumanta; Koralewski, Piotr; Stroyakovskiy, Daniil; Alekseev, Boris; Parnis, Francis; Castellano, Daniel; Lyun Lee, Jae; Sunela, Kaisa; Ciuleanu, Tudor; Heng, Daniel; Glen, Hilary; Wang, Jinyi; Bennett, Lee; Pan, Janice; O'Hara, Karen; Puente, Javier

Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer

达罗鲁胺与转移性激素敏感性前列腺癌的生存率

Smith, Matthew R; Hussain, Maha; Saad, Fred; Fizazi, Karim; Sternberg, Cora N; Crawford, E David; Kopyltsov, Evgeny; Park, Chandler H; Alekseev, Boris; Montesa-Pino, Álvaro; Ye, Dingwei; Parnis, Francis; Cruz, Felipe; Tammela, Teuvo L J; Suzuki, Hiroyoshi; Utriainen, Tapio; Fu, Cheng; Uemura, Motohide; Méndez-Vidal, María J; Maughan, Benjamin L; Joensuu, Heikki; Thiele, Silke; Li, Rui; Kuss, Iris; Tombal, Bertrand

Health-Related Quality of Life in Metastatic, Hormone-Sensitive Prostate Cancer: ENZAMET (ANZUP 1304), an International, Randomized Phase III Trial Led by ANZUP

转移性激素敏感性前列腺癌患者的健康相关生活质量:ENZAMET (ANZUP 1304),一项由 ANZUP 牵头的国际随机 III 期试验

Stockler, Martin R; Martin, Andrew J; Davis, Ian D; Dhillon, Haryana M; Begbie, Stephen D; Chi, Kim N; Chowdhury, Simon; Coskinas, Xanthi; Frydenberg, Mark; Hague, Wendy E; Horvath, Lisa G; Joshua, Anthony M; Lawrence, Nicola J; Marx, Gavin M; McCaffrey, John; McDermott, Ray; McJannett, Margaret; North, Scott A; Parnis, Francis; Parulekar, Wendy R; Pook, David W; Reaume, M Neil; Sandhu, Shahneen; Tan, Alvin; Tan, Thean Hsiang; Thomson, Alastair; Vera-Badillo, Francisco; Williams, Scott G; Winter, Diana G; Yip, Sonia; Zhang, Alison Y; Zielinski, Robert R; Sweeney, Christopher J

A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg Per Day Compared with the Cabozantinib Capsule at 140 mg Per Day in Patients with Progressive, Metastatic Medullary Thyroid Cancer

一项随机、双盲、非劣效性研究,旨在评估每日60毫克卡博替尼片剂与每日140毫克卡博替尼胶囊在进展性转移性甲状腺髓样癌患者中的疗效。

Capdevila, Jaume; Klochikhin, Arkadiy; Leboulleux, Sophie; Isaev, Pavel; Badiu, Corin; Robinson, Bruce; Hughes, Brett G M; Keam, Bhumsuk; Parnis, Francis; Elisei, Rossella; Gajate, Pablo; Gan, Hui K; Kapiteijn, Ellen; Locati, Laura; Mangeshkar, Milan; Faoro, Leonardo; Krajewska, Jolanta; Jarzab, Barbara